ABBOTT PARK, Ill. and BETHESDA, Md. , Aug. 17, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) and the National Association of Community Health Centers (NACHC) announced a multi-year "food is medicine" effort...
ABBOTT PARK, Ill. and ROSEMONT, Ill. , Aug. 12, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, and the Big Ten Conference today announced the return of the "We Give Blood"...
ABBOTT PARK, Ill. , Aug. 11, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced a first-of-its-kind partnership with Google Health to redefine how people understand and manage their health....
Solventum shares gain on strong Q2 revenue, earnings, and cash flow, buybacks, and improved guidance, with analysts raising price targets amid a discounted valuation versus med/tech peers.
/Abbott%20Laboratories%20HQ%20photo-%20by%20Sundry%20Photography%20via%20iStock.jpg)
Abbott has lagged behind the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects.
Veeva Systems is scheduled to post its second-quarter results soon, and analysts project a double-digit earnings growth.
Abbott's diversified healthcare business is one of the main reasons why it remains a reliable dividend stock.
Charles River Laboratories is poised to announce its second-quarter results next month, and analysts predict a double-digit drop in the company’s bottom-line figure.
/Bio-Techne%20ground%20sign%20outside%20of%20the%20office%20in%20San%20Jose%2C%20California%2C%20USA%20-%20June%208%2C%202023_%20By%20JHVEPhoto.jpeg)
Bio-Techne is scheduled to post its fourth-quarter results soon, and analysts project a single-digit earnings decline.
/Cencora%20Inc_%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
Cencora is scheduled to release its third-quarter results next month, with analysts projecting single-digit earnings growth.